Cargando…
Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864178/ https://www.ncbi.nlm.nih.gov/pubmed/35223878 http://dx.doi.org/10.3389/fmed.2021.751110 |
_version_ | 1784655400477392896 |
---|---|
author | Levink, Iris J. M. Brosens, Lodewijk A. A. Rensen, Sander S. Aberle, Merel R. Olde Damink, Steven S. W. Cahen, Djuna L. Buschow, Sonja I. Fuhler, Gwenny M. Peppelenbosch, Maikel P. Bruno, Marco J. |
author_facet | Levink, Iris J. M. Brosens, Lodewijk A. A. Rensen, Sander S. Aberle, Merel R. Olde Damink, Steven S. W. Cahen, Djuna L. Buschow, Sonja I. Fuhler, Gwenny M. Peppelenbosch, Maikel P. Bruno, Marco J. |
author_sort | Levink, Iris J. M. |
collection | PubMed |
description | INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. RESULTS: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. DISCUSSION: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival. |
format | Online Article Text |
id | pubmed-8864178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88641782022-02-24 Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival Levink, Iris J. M. Brosens, Lodewijk A. A. Rensen, Sander S. Aberle, Merel R. Olde Damink, Steven S. W. Cahen, Djuna L. Buschow, Sonja I. Fuhler, Gwenny M. Peppelenbosch, Maikel P. Bruno, Marco J. Front Med (Lausanne) Medicine INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. RESULTS: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. DISCUSSION: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival. Frontiers Media S.A. 2022-02-09 /pmc/articles/PMC8864178/ /pubmed/35223878 http://dx.doi.org/10.3389/fmed.2021.751110 Text en Copyright © 2022 Levink, Brosens, Rensen, Aberle, Olde Damink, Cahen, Buschow, Fuhler, Peppelenbosch and Bruno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Levink, Iris J. M. Brosens, Lodewijk A. A. Rensen, Sander S. Aberle, Merel R. Olde Damink, Steven S. W. Cahen, Djuna L. Buschow, Sonja I. Fuhler, Gwenny M. Peppelenbosch, Maikel P. Bruno, Marco J. Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title | Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title_full | Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title_fullStr | Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title_full_unstemmed | Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title_short | Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival |
title_sort | neoantigen quantity and quality in relation to pancreatic cancer survival |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864178/ https://www.ncbi.nlm.nih.gov/pubmed/35223878 http://dx.doi.org/10.3389/fmed.2021.751110 |
work_keys_str_mv | AT levinkirisjm neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT brosenslodewijkaa neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT rensensanders neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT aberlemerelr neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT oldedaminkstevensw neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT cahendjunal neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT buschowsonjai neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT fuhlergwennym neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT peppelenboschmaikelp neoantigenquantityandqualityinrelationtopancreaticcancersurvival AT brunomarcoj neoantigenquantityandqualityinrelationtopancreaticcancersurvival |